Biologic meshes and synthetic meshes in cancer patients: a double-edged sword: differences in production of IL-6 and IL-12 caused by acellular dermal matrices in human immune cells

Karsten, MM; Enders, S; Knabl, J; Kirn, V; Duwell, P; Rack, B; Blohmer, JU; Mayr, D; Dian, D

Karsten, MM (reprint author), Charite, Klin Gynakol, Campus Charite Mitte, Charitepl 1, D-10117 Berlin, Germany.

ARCHIVES OF GYNECOLOGY AND OBSTETRICS, 2018; 297 (5): 1265

Abstract

In 2005, Breuing et al. first described the use of acellular dermal matrices (ADMs) in breast cancer patients. ADMs are assumed to be safe to use in a......

Full Text Link